Cargando…
Could CT screening for lung cancer ever be cost effective in the United Kingdom?
BACKGROUND: The absence of trial evidence makes it impossible to determine whether or not mass screening for lung cancer would be cost effective and, indeed, whether a clinical trial to investigate the problem would be justified. Attempts have been made to resolve this issue by modelling, although t...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2292150/ https://www.ncbi.nlm.nih.gov/pubmed/18302756 http://dx.doi.org/10.1186/1478-7547-6-5 |